North America's largest commercial pharma event comes back for its 18th annual year - Let’s get ahead of this crisis and come together to define a better way forward for value-based care where pharma can become healthcare's solution.
Join 1000+ pharma decision-makers and healthcare innovators to:
- Join forces with providers: Strategic engagements are bringing results. Scale creative partnerships with providers and join our IDN Panel to hear what your customer really wants.
Sustain breakthrough innovations: Industry heavyweights join MIT NEWDIGS, ICER, NPC, TransCelerate, the FDA and patient groups to present a roadmap of how we ensure access.
The future is here: Our new Innovation Stage showcases breakthroughs in AI, immersive media and blockchain. Our Digital and Marketing Stage provides practical tools to implement.
The patient comes first: Collaborate with your most important stakeholder, see how patient entrepreneurs are turning bad into good, and implement patient-first transformation.
Why you need to attend:
- A cross-functional audience.Everyone in commercial pharma is there, all learning from each other.
- Ambitions to redefine pharma as the solution provider.Not just to run another conference.
- Over 80 solution providers.If you want to go shopping, this is the place to find the perfect partner.
- Curated content.Hundreds upon hundreds of conversations go into preparing our agendas to ensure they’re tailored to your needs.
- Case-study heavy.You need to see real, detailed examples. Our speakers will provide you with them.
Price:
Pharma Silver Pass: USD 1999.00
Speakers: Chris Leibman SVP, Value and Access, Biogen, Ivan Cheung, CEO and President, Eisai Inc., Jackie Hunter, CE Clinical and Strategic Partnerships, Benevolent AI, Jeff Marrazzo, CEO, Spark Therapeutics, Marc Boutin, CEO, The National Health Council, Ramona Sequeira, President, Takeda U.S.A, Rob Scott, CMO, Abbvie, Sebastian Guth, President, Americas, Bayer, Sarah Emond, EVP and COO, ICER, AmyNicole Nayar, Head, Global Patient relations, Abbvie, Bharti Rai, VP Commercial Acceleration/ Effectiveness, Novartis, Christian Scheuer, VP Global Commercial Affairs and Excellence, LEO Pharma, Dalvir Gill, CEO, Transcelerate, Doug Stover, VP, Global Head of Patient Experience and Technology Practice , UCB, Eddie Power, VP, North America Medical Affairs, Hospital Business, Pfizer, Ester Banque, SVP and Head Intercontinental Commercial, Bristol-Myers Squibb, Eric Racine, VP and Head, North America Public Affairs and Patient Advocacy, Sanofi
Join 1000+ pharma decision-makers and healthcare innovators to:
- Join forces with providers: Strategic engagements are bringing results. Scale creative partnerships with providers and join our IDN Panel to hear what your customer really wants.
Sustain breakthrough innovations: Industry heavyweights join MIT NEWDIGS, ICER, NPC, TransCelerate, the FDA and patient groups to present a roadmap of how we ensure access.
The future is here: Our new Innovation Stage showcases breakthroughs in AI, immersive media and blockchain. Our Digital and Marketing Stage provides practical tools to implement.
The patient comes first: Collaborate with your most important stakeholder, see how patient entrepreneurs are turning bad into good, and implement patient-first transformation.
Why you need to attend:
- A cross-functional audience.Everyone in commercial pharma is there, all learning from each other.
- Ambitions to redefine pharma as the solution provider.Not just to run another conference.
- Over 80 solution providers.If you want to go shopping, this is the place to find the perfect partner.
- Curated content.Hundreds upon hundreds of conversations go into preparing our agendas to ensure they’re tailored to your needs.
- Case-study heavy.You need to see real, detailed examples. Our speakers will provide you with them.
Price:
Pharma Silver Pass: USD 1999.00
Speakers: Chris Leibman SVP, Value and Access, Biogen, Ivan Cheung, CEO and President, Eisai Inc., Jackie Hunter, CE Clinical and Strategic Partnerships, Benevolent AI, Jeff Marrazzo, CEO, Spark Therapeutics, Marc Boutin, CEO, The National Health Council, Ramona Sequeira, President, Takeda U.S.A, Rob Scott, CMO, Abbvie, Sebastian Guth, President, Americas, Bayer, Sarah Emond, EVP and COO, ICER, AmyNicole Nayar, Head, Global Patient relations, Abbvie, Bharti Rai, VP Commercial Acceleration/ Effectiveness, Novartis, Christian Scheuer, VP Global Commercial Affairs and Excellence, LEO Pharma, Dalvir Gill, CEO, Transcelerate, Doug Stover, VP, Global Head of Patient Experience and Technology Practice , UCB, Eddie Power, VP, North America Medical Affairs, Hospital Business, Pfizer, Ester Banque, SVP and Head Intercontinental Commercial, Bristol-Myers Squibb, Eric Racine, VP and Head, North America Public Affairs and Patient Advocacy, Sanofi
